Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
It shouldn’t take hindsight to read the fine print in your 23andme contract. They straight up told folks, that taking their test meant signing over ownership of your DNA samples to them, for whatever future purpose they had in mind.
Anyone who didn’t clue in to the fact that meant they were paying that company to own the rights to their DNA, is an idiot.